Author: Melanie Govindasamy

UPDATE ON COVID-19 HEALTH PRODUCTS: SAHPRA registers the Covovax COVID-19 vaccine from Cipla (Pty) Ltd and additional indication of use of COVID-19 vaccine MC Pharma from MC Pharma (Pty) Ltd in the age group 3 -17 years. Pretoria, 28 September 2022 – SAHPRA registered a COVID-19...

Patient safety resonates with SAHPRA’s mission of ensuring that the public is protected by registering and regulating all health products so that they comply with SAHPRA’s pillars of safety, quality, efficacy and performance. This involves ensuring that stringent regulatory requirements are followed before any health product is made...

KwaZulu-Natal, 12 September 2022 – SAHPRA is planning on visiting universities that offer studies relating to pharmacy and medicines. These visits will create an awareness about SAHPRA to students.  Its mandate and its roles and responsibilities include educating the students about the Authority’s programmes. There will...

The Communications and Public Relations Unit has re-evaluated the navigation of the South African Health Products Regulatory Authority (SAHPRA) website to create a more seamless user experience. We have changed both the main and secondary navigations. MAIN NAVIGATION ​​​​​​​The main navigation has changed from this: To this: SECONDARY NAVIGATION ​​​​​​​The secondary...

Johannesburg, 06 August 2022 - The South African Health Products Regulatory Authority (SAHPRA) was invited to speak at this year’s South African Association of Pharmacists in Industry (SAAPI) Conference during 03-05 August 2022 sharing vital information across core functional areas of the organisation. SAHPRA was...

Pretoria, 22 July 2022 - SAHPRA CEO, Dr Boitumelo Semete-Makokotlela, clinched a Management Award at last night's 24th National Science and Technology Forum (NSTF) Awards, that recognises outstanding contributions to science, engineering and technology (SET), and innovation. According to NSTF, Dr Semete-Makokotlela earned her accolade as...